Compounded liothyronine sodium (T3), an oral thyroid hormone prescribed by a licensed DrWell provider based on lab work and clinical evaluation, and monitored throughout treatment. Compounded medications are not FDA approved.
Compounded drugs are not FDA approved. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.

Images are for illustrative purposes only. Actual medication appearance, packaging, and labeling may vary by pharmacy.



Liothyronine sodium is the active form of thyroid hormone, also called T3. A licensed DrWell provider may prescribe it as thyroid hormone replacement for patients with a clinically diagnosed thyroid hormone deficiency, based on symptoms, examination and thyroid lab results.
This medication is compounded. It is prepared by a licensed pharmacy for an individual patient based on a prescription, and strengths such as 5 mcg may be used depending on the prescription. Compounded medications are not FDA approved, which means the FDA has not evaluated their safety, effectiveness or quality.
Thyroid hormones help regulate how the body uses energy, including heart rate, body temperature and metabolism. Liothyronine supplies T3 directly, so it does not need to be converted from T4 (levothyroxine) by the body.
Your provider determines the dose and schedule and may adjust them based on your lab results and how you respond.
Treatment begins only after a provider reviews your symptoms, health history and thyroid lab results. Doses are adjusted gradually, and follow-up lab work continues for as long as you remain on therapy.
Your provider sets your dose and schedule. Individual responses vary, and results are not guaranteed.
Whether thyroid hormone is appropriate for you is a decision made by a licensed provider based on your symptoms, examination, laboratory results and health history. It is not appropriate for everyone and requires ongoing monitoring.
This page is general information and is not medical advice.
Side effects are most often related to too much thyroid hormone and can include a fast or irregular heartbeat, palpitations, chest pain, tremor, anxiety, trouble sleeping, heat intolerance, sweating, headache, diarrhea and weight loss.
Serious effects can include heart rhythm problems, worsening of heart conditions, and reduced bone density with long-term over-treatment. Allergic reactions are possible. Contact your provider promptly about chest pain, a rapid heartbeat or shortness of breath.
This is not a complete list. Ask your provider about the full prescribing information.
Compounded drugs are not FDA approved. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.
Medication availability, formulation, packaging and pharmacy fulfillment vary based on the patient's prescription and location.
Boxed warning. Thyroid hormones, including liothyronine, should not be used for the treatment of obesity or for weight loss. In people with normal thyroid levels, larger doses may produce serious or even life-threatening signs of toxicity, especially when taken with other medications that suppress appetite.
Compounded medication. This medication is compounded by a licensed pharmacy and is not FDA approved. The FDA has not evaluated compounded medications for safety, effectiveness or quality. It is prescribed for an individual patient by a licensed provider.
Who should be cautious. Tell your provider if you have heart disease, high blood pressure, diabetes, adrenal problems, are pregnant or planning to become pregnant, or take blood thinners, diabetes medication or other thyroid medication. Doses may need to change.
Monitoring. Your provider should monitor your thyroid lab values and symptoms during treatment.
Not medical advice. The information on this page is general and educational. It does not establish a provider relationship and does not replace a consultation with a licensed provider.
Liothyronine sodium is the active form of thyroid hormone, also called T3. A licensed provider may prescribe it as thyroid hormone replacement for patients with a clinically diagnosed thyroid hormone deficiency. The version offered here is compounded.
No. It is compounded by a licensed pharmacy, and compounded medications are not FDA approved. The FDA has not evaluated them for safety, effectiveness or quality.
Yes. A provider reviews your thyroid lab results and health history before deciding whether treatment is appropriate. Follow-up labs continue throughout treatment.
Liothyronine is T3, the active form of thyroid hormone. Levothyroxine is T4, which the body converts to T3. Levothyroxine is available as FDA approved products, and compounded liothyronine is not FDA approved. Your provider can discuss which option fits your situation.
Some providers prescribe T3 and T4 together. Whether that is appropriate for you is your provider's decision, based on your labs and symptoms. Do not combine thyroid medications on your own.
The dose is individualized. Your provider chooses your starting dose, adjusts it gradually based on your labs and symptoms, and tells you how and when to take it. Do not change your dose on your own.
Side effects are most often related to too much thyroid hormone and can include a fast or irregular heartbeat, palpitations, chest pain, tremor, anxiety, trouble sleeping, heat intolerance, sweating, headache, diarrhea and weight loss. See the side effects section above and ask your provider about the full prescribing information.
No. Thyroid hormones should not be used to treat obesity or to lose weight. Taking them for that purpose can cause serious, even life-threatening, toxicity.
Prescriptions can be written by a licensed DrWell provider after an evaluation of your symptoms, health history and thyroid lab results. Whether treatment is appropriate is the provider's decision.
Costs vary. They depend on your prescribed dose, your pharmacy and the lab work required. Your DrWell provider can explain what applies to you.
Contact your prescribing provider. Seek urgent care for chest pain, a rapid or irregular heartbeat, or trouble breathing.